These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15231250)

  • 1. New drugs for treatment of multiple myeloma.
    Bruno B; Rotta M; Giaccone L; Massaia M; Bertola A; Palumbo A; Boccadoro M
    Lancet Oncol; 2004 Jul; 5(7):430-42. PubMed ID: 15231250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding novel therapeutic agents for multiple myeloma.
    Tariman JD
    Clin J Oncol Nurs; 2003; 7(5):521-8. PubMed ID: 14603548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging role of arsenic trioxide as an immunomodulatory agent in the management of multiple myeloma.
    Kalmadi SR; Hussein MA
    Acta Haematol; 2006; 116(1):1-7. PubMed ID: 16809883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findings.
    Ocio EM; Mateos MV; Maiso P; Pandiella A; San-Miguel JF
    Lancet Oncol; 2008 Dec; 9(12):1157-65. PubMed ID: 19038762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapies for multiple myeloma.
    Ryoo JJ; Cole CE; Anderson KC
    Blood Rev; 2002 Sep; 16(3):167-74. PubMed ID: 12163002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myeloma.
    Rajkumar SV; Witzig TE
    Cancer Treat Rev; 2000 Oct; 26(5):351-62. PubMed ID: 11006136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nontraditional cytotoxic therapies for relapsed/refractory multiple myeloma.
    Hussein MA
    Oncologist; 2002; 7 Suppl 1():20-9. PubMed ID: 11961206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel therapies for multiple myeloma.
    Hayashi T; Hideshima T; Anderson KC
    Br J Haematol; 2003 Jan; 120(1):10-7. PubMed ID: 12492571
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug insight: thalidomide as a treatment for multiple myeloma.
    Kumar S; Anderson KC
    Nat Clin Pract Oncol; 2005 May; 2(5):262-70. PubMed ID: 16264962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting multiple myeloma cells and their bone marrow microenvironment.
    Pagnucco G; Cardinale G; Gervasi F
    Ann N Y Acad Sci; 2004 Dec; 1028():390-9. PubMed ID: 15650264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted therapy of multiple myeloma based upon tumor-microenvironmental interactions.
    Anderson KC
    Exp Hematol; 2007 Apr; 35(4 Suppl 1):155-62. PubMed ID: 17379101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma: present and future.
    Hussein MA; Juturi JV; Lieberman I
    Curr Opin Oncol; 2002 Jan; 14(1):31-5. PubMed ID: 11790977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor and its receptors in multiple myeloma.
    Ria R; Roccaro AM; Merchionne F; Vacca A; Dammacco F; Ribatti D
    Leukemia; 2003 Oct; 17(10):1961-6. PubMed ID: 14513045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bone marrow angiogenesis in multiple myeloma: new insights into the pathogenesis, and development of a new therapeutic approach].
    Hattori Y; Kakimoto T
    Rinsho Ketsueki; 2000 May; 41(5):426-9. PubMed ID: 10879105
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiangiogenesis in myelodysplastic syndrome.
    Aguayo A; Armillas-Canseco FM; Martínez-Baños D
    Curr Cancer Drug Targets; 2011 Nov; 11(9):1044-52. PubMed ID: 21999628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide: present and future in multiple myeloma.
    Hussein MA
    Expert Rev Anticancer Ther; 2005 Feb; 5(1):25-31. PubMed ID: 15757435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overview of drug therapy for multiple myeloma.
    Saunders G
    J Oncol Pharm Pract; 2005 Sep; 11(3):83-100. PubMed ID: 16390597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thalidomide--new prospective therapy in oncology].
    Pałgan K; Pałgan I
    Wiad Lek; 2003; 56(9-10):455-9. PubMed ID: 15049211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New drugs in multiple myeloma.
    Berenson JR; Yellin O
    Curr Opin Support Palliat Care; 2008 Sep; 2(3):204-10. PubMed ID: 18685422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of thalidomide in the treatment of multiple myeloma].
    Mikala G; Jákó J; Vályi-Nagy I
    Orv Hetil; 2001 Aug; 142(33):1789-98. PubMed ID: 11573449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.